Mutu obat harus terjamin sepanjang jalur penyaluran sesuai persyaratan dan tujuan penggunaannya. Semua pihak yang terlibat dalam penyaluran obat dan/atau bahan obat bertanggung jawab untuk memastikan mutu obat dan/atau bahan obat dan mempertahankan integritas rantai penyaluran selama proses distribusi. Ketentuan cara penyaluran obat dan/atau bahan obat diatur dalam Cara Distribusi Obat yang Baik (CDOB) yang harus diterapkan oleh PBF sebagai pelaku yang memiliki izin dalam distribusi obat. Oleh karena itu, untuk memastikan mutu obat dan/atau bahan obat tetap terjaga, perlu diketahui implementasi dari SOP mengenai pengadaan, penerimaan, penyimpanan, dan penyaluran di PT Kimia Farma Trading & Distribution Jakarta 2 yang dituliskan berdasarkan CDOB. Hasil observasi pengadaan, penerimaan, penyimpanan, dan penyaluran obat regular di PT Kimia Farma Trading & Distribution Jakarta 2 dibandingkan dengan SOP dan CDOB terkait, dan dilakukan gap analysis dari hasil perbandingan tersebut. Dalam tugas khusus ini, SOP terkait pengadaan, penerimaan, penyimpanan, dan penyaluran di PT Kimia Farma Trading & Distribution Jakarta 2 sesuai Cara Distribusi Obat yang Baik (CDOB) tahun 2020 dan sudah diimplementasikan dengan baik.

---

The quality of medicines must be guaranteed along the distribution or distribution route according to the requirements and intended use. All parties involved in the distribution of drugs and/or medicinal substances are responsible for ensuring the quality of drugs and/or medicinal substances and maintaining the integrity of the distribution chain during the distribution process. Provisions for distributing medicines and/or medicinal substances are regulated in Good Distribution Practice (GDP) which must be implemented by pharmaceutical wholesaler as actors who have permits in the distribution of medicines. Therefore, to ensure that the quality of drugs and/or medicinal substances is maintained, it is necessary to know the implementation of the SOP regarding procurement, receiving, storage and distribution at PT Kimia Farma Trading & Distribution Jakarta 2 which is written based on GDP. The results of observations of the procurement, receiving, storage and distribution of regular medicines at PT Kimia Farma Trading & Distribution Jakarta 2 were compared with the relevant SOP and CDOB, and a gap analysis was carried out from the comparison results. In this report, the SOPs related to procurement, receiving, storage and distribution at PT Kimia Farma Trading & Distribution Jakarta 2 are in accordance with the 2020 Good Distribution Practice (GDP) and have been implemented well.